Paxlovid: Is Africa Ready For The New Phase Of Covid-19 Treatment?

 Paxlovid: Is Africa Ready For The New Phase Of Covid-19 Treatment?

In November 2021, a mid-to-late stage study showed that an antiviral medication was nearly 90% effective in preventing hospitalisations and deaths in adults at high risk of severe illness. By December, the Paxlovid was cleared for Emergency Use Authorization (EUA) by the Food and Drug Administration (FDA) in America and…

You must be registered to view this content.
Register for free | Login

Patsy Nwogu

A writer focused on data journalism, health and data analytics.

Related post